Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Medtronic
Merck
Argus Health
Chubb
Dow
Baxter
Healthtrust
Fish and Richardson

Generated: July 23, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR COLESTIPOL HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for colestipol hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00000512 Familial Atherosclerosis Treatment Study Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 To compare the effects of two intensive lipid-lowering regimens with conventional therapy on coronary atherosclerosis as assessed by arteriography.
NCT00000512 Familial Atherosclerosis Treatment Study Completed University of Washington Phase 3 To compare the effects of two intensive lipid-lowering regimens with conventional therapy on coronary atherosclerosis as assessed by arteriography.
NCT00000599 Cholesterol-Lowering Atherosclerosis Study (CLAS) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 To determine whether combined therapy with the lipid lowering agents colestipol hydrochloride plus niacin would produce significant change in coronary, carotid, and femoral artery atherosclerosis and coronary bypass graft lesions as determined by angiography. Also, to determine possible correlations between lesion changes and plasma lipid and lipoprotein cholesterol levels and to explore interrelationships of atherosclerosis change in femoral, coronary, and carotid arteries.
NCT00116870 MARS - Monitored Atherosclerosis Regression Study Completed Merck Sharp & Dohme Corp. Phase 2/Phase 3 The purpose of this study is to determine whether significant alterations in serum lipoproteins as provided by the drug lovastatin can substantially reduce atherosclerosis progression or even induce regression.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Clinical Trial Conditions for colestipol hydrochloride

Condition Name

Condition Name for colestipol hydrochloride
Intervention Trials
Coronary Arteriosclerosis 2
Heart Diseases 2
Myocardial Ischemia 2
Cardiovascular Diseases 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for colestipol hydrochloride
Intervention Trials
Atherosclerosis 4
Coronary Disease 3
Coronary Artery Disease 3
Myocardial Ischemia 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for colestipol hydrochloride

Trials by Country

Trials by Country for colestipol hydrochloride
Location Trials
United States 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for colestipol hydrochloride
Location Trials
Alabama 1
California 1
Florida 1
Massachusetts 1
Missouri 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for colestipol hydrochloride

Clinical Trial Phase

Clinical Trial Phase for colestipol hydrochloride
Clinical Trial Phase Trials
Phase 4 2
Phase 3 2
Phase 2/Phase 3 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for colestipol hydrochloride
Clinical Trial Phase Trials
Completed 7
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for colestipol hydrochloride

Sponsor Name

Sponsor Name for colestipol hydrochloride
Sponsor Trials
National Heart, Lung, and Blood Institute (NHLBI) 2
Merck Sharp & Dohme Corp. 2
Derrick Scott Robertson 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for colestipol hydrochloride
Sponsor Trials
Other 10
Industry 4
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Mallinckrodt
Cantor Fitzgerald
Argus Health
Cipla
Fuji
Chinese Patent Office
McKinsey
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.